Hospitalization – Page 18 – Communicable Diseases Research

Sustained seropositivity up to 20.5 months after COVID-19

Article

Published on 2022-10-132022-11-15
Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술,

[키워드] absence addition affecting age anosmia/hypogeusia Anti-spike antibodies antibody antibody level Barcelona Beta chest pain circulating Cohort Comorbidity comparable COVID-19 cutaneous symptom Delta Duration duration of symptoms evaluated Factor faster Fever FIVE Frequency Gamma headache Health care Health care worker health care workers Hospitalization Humoral immunity hypertension IgA IgA response IgG IgM Infection initial Kinetics long-lasting multivariable regression models nucleocapsid antigen obesity onset of symptom oxygen supply pandemic participant persistence predominant protective role Reinfection remained responders response SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 spike Seroprevalence smoking Spain STABLE study period subset sustained Tachycardia vaccination variant variants of concern Wuhan
[DOI] 10.1186/s12916-022-02570-3 PMC 바로가기

Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk

Article

Published on 2022-10-112022-11-15
Journal: Medicina [Category] COVID19(2023년), SARS, 바이오마커,

[키워드] acute respiratory syndrome Admission age Alpha alveolar ambient biochemical biochemical marker Biomarker C reactive protein can be used cardiac injury chest scan Computerized tomography consecutive patients consolidation coronavirus correlated correlation COVID-19 COVID-19 complications COVID-19 patient COVID-19 risk factors CRP CT scan Diastolic blood pressure dysfunction elevated estimate Factor Factors fibrinogen group Hospitalization IL-6 Infection Inflammatory marker Injury interleukin-6 interlobular septal thickening interstitial Involvement lactate dehydrogenase LDH lesion lung Lung disease lung involvement material multisystemic myocardial injury myocardial involvement Myoglobin Necrosis non-specific NT-proBNP objective Observational cohort study occurred parameters pathology Patient Patient care performed peripheral oxygen saturation Pneumonia pulmonary pulmonary involvement pulmonary lobe radiological Registered respiratory rate respiratory rates Result risk routine SARS-CoV-2 SARS-COV-2 infection Serum ferritin severity Sex significant difference Systolic blood pressure the disease the patient the study group TnI
[DOI] 10.3390/medicina58101436 PMC 바로가기

Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients

Article

Published on 2022-10-112022-11-15
Journal: PLoS ONE [Category] 바이오마커,

[키워드] addition age Biomarker body mass index C-reactive protein Chronic kidney disease CKD conducted coronavirus disease COVID-19 COVID-19 patient COVID-19 patients CRP CRP level D-dimer demonstrated diabetes discharged disease severity enrolled enzyme-linked immunosorbent examined glomerular filtration rate Hospitalization hospitalized patient Hyperinflammatory hypertension ICU ICU patient IL-6 influence intensive care Lactate Logistic regression analysis lymphocyte counts male males median Mortality multivariate Necrosis parameters Patient patients died patients with COVID-19 Prognosis receive receptor reported Retrospective study Serum level severity Significant significantly higher the patient TNF TNFR1 TNFR2 Treatment university utility were measured White blood cells
[DOI] 10.1371/journal.pone.0275745 PMC 바로가기

Risk of severe COVID-19 infection in persons with diabetes during the first and second waves in Denmark: A nationwide cohort study

Article

Published on 2022-10-112023-07-10
Journal: Frontiers in Endocrinology [Category] COVID19(2023년),

[키워드] cardiovascular disease COVID-19 diabetes Hospitalization hypertension Microvascular disease obesity SARS-CoV-2
[DOI] 10.3389/fendo.2022.1025699 PMC 바로가기

Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection

Article

Published on 2022-10-102022-11-15
Journal: Scientific Reports [Category] COVID19(2023년), SARS, 비임상, 진단,

Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study

Article

Published on 2022-10-082022-11-15
Journal: BMC Neurology [Category] COVID19(2023년), SARS, 진단,

Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies

Article

Published on 2022-10-042022-11-15
Journal: Transplant International [Category] COVID19(2023년), SARS, 변종, 진단,

Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals

Article

Published on 2022-10-032022-11-15
Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 치료제,

[키워드] 95% CI adjusted odds ratio Affair age antiviral therapy association benefit black blood oxygen level booster booster vaccination Breakthrough infection Characteristics Chemotherapy chronic condition Chronic kidney disease collected Comorbidities conditions COVID-19 death defined Dementia demographic Department development Dexamethasone diagnostic disease dose effort end-organ Factor finding heart failure Hispanic Hospitalization hospitals identify immunocompromised status Immunosuppressive medication increase in increased risk Infection laboratory-confirmed SARS-CoV-2 infection less leukemia leukocyte logistic regression models lymphoma male mechanical ventilation men Older outcome Patient positive preexposure prophylaxis proportion receipt reduced retrospective cohort retrospective cohort study risk risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination severe COVID-19 severe COVID-19 disease severe disease Severe infection supplemental oxygen treated vaccination Vaccine variables veteran veterans white
[DOI] 10.1001/jamanetworkopen.2022.40037 PMC 바로가기

Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada

Article

Published on 2022-10-032022-11-16
Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, 치료기술,

[키워드] 95% CI adjusted Against age Care case-control study conducted dose doses Estimated female genomic greater Health Heterologous Hospitalization individual individuals Infection laboratory-confirmed laboratory-confirmed SARS-CoV-2 infection messenger Messenger RNA mRNA mRNA vaccination mRNA vaccine Odds ratio Older omicron outcome participant Participants phylogenetically Postinfection Prevent protection provided quantification Quebec, Canada reduction Reinfection risk risk reduction SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severity Sex significantly higher stratified Surveillance tested vaccinated individual vaccination Vaccine vaccine dose vaccine strain variant
[DOI] 10.1001/jamanetworkopen.2022.36670 PMC 바로가기

Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2

퀸즐랜드의 무리 면역 요구 사항 모델링: 백신 접종 효과의 영향, SARS-CoV-2의 주저 및 변종

Article

Published on 2022-10-032022-09-11
Journal: Philosophical transactions. Series A, Mathematical [Category] COVID19(2023년), SARS, 변종,